COMMUNIQUÉS West-GlobeNewswire

Parexel Establishes New Global Headquarters in Raleigh’s North Hills Innovation District
09/09/2025
Company relocation within the Raleigh-Durham area underscores commitment to sustainability, workplace innovation and strong presence in North Carolina RALEIGH, N.C., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Parexel, a leading [...]
Aviv Clinics Showcases New Study on Hyperbaric Oxygen Therapy’s Effectiveness in Improving Post-Concussion Symptoms from Childhood Traumatic Brain Injury
09/09/2025
Study demonstrates how hyperbaric oxygen therapy can improve cognitive function in adults with long-term effects of childhood brain injury, offering new hope for post-concussion syndrome patients ORLANDO, Fla., Sept. 09 [...]
All Heart Homecare Expands Services with Specialized Holocaust Program
09/09/2025
BROOKLYN, N.Y., Sept. 09, 2025 (GLOBE NEWSWIRE) -- All Heart Homecare — Brooklyn’s premier home care agency and a trusted partner for families across New York City for over 13 years — is proud to expand its wide range [...]
Scenic Biotech Appoints Dr. Roland W. Bürli as CSO to Advance Pipeline of Modifier Therapies in Neuro- and Metabolic Diseases
09/09/2025
Scenic Biotech taps Dr. Bürli as Chief Scientific Officer to lead development of innovative drug candidate pipeline fueled by the company’s Cell-Seq platform. Amsterdam, the Netherlands, September 09, 2025 – Scenic [...]
RYBREVANT®▼ (amivantamab) en association avec LAZCLUZE®▼ (lazertinib) réduit la résistance acquise à l’osimertinib dans le traitement de première intention du cancer du poumon non à petites cellules avancé avec mutations de l’EGFR
09/09/2025
De nouvelles données démontrent que l’association avec l’amivantamab réduit significativement les mutations courantes de résistance à l’EGFR et au MET observées avec les ITK de l’EGFR 1 BEERSE, BELGIQUE, Sept. 09, 2025 [...]
Biosplice Therapeutics Announces First Patient Dosed in NCI-Sponsored Clinical Trial of Cirtuvivint in Acute Myeloid Leukemia and Myelodysplastic Syndromes
09/09/2025
SAN DIEGO, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Biosplice Therapeutics, Inc. (“Biosplice”), a clinical-stage biotechnology company pioneering advancements in small molecule inhibition of CDC-like kinases (CLK) and Dual- [...]
Persephone Biosciences Unveils First-Of-Its-Kind Synbiotic Designed To Restore Critical Gut Microbes In Babies
09/09/2025
Newly released data shows that nine in ten babies lack critical gut microbes needed for healthy development. Persephone’s Daily Synergistic Synbiotic, built on the largest and most comprehensive U.S. infant gut [...]
CHAPPER healthcare, AscellaHealth’s Global Pharmaceutical Distributor, Assumes Presidency of EUROPACCESS, Enhancing Access to Innovative Medicines
09/09/2025
WATFORD, United Kingdom and BERWYN, Pa., Sept. 09, 2025 (GLOBE NEWSWIRE) -- CHAPPER healthcare , AscellaHealth’s global pharmaceutical wholesaler, distributor and commercialization service provider, announces its [...]
Amgen and Kyowa Kirin Announce Top-Line Results From Rocatinlimab Phase 3 ASCEND Long-Term Extension Study in Adults With Moderate to Severe Atopic Dermatitis
09/09/2025
THOUSAND OAKS, Calif. and TOKYO, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Amgen (NASDAQ:AMGN) and Kyowa Kirin Co., Ltd. (TSE:4151) today announced preliminary top-line results from the ASCEND study evaluating rocatinlimab, an [...]
Novartis to acquire Tourmaline Bio, complementing cardiovascular pipeline with pacibekitug for the treatment of atherosclerotic cardiovascular disease (ASCVD)
09/09/2025
Tourmaline Bio is a clinical-stage biopharmaceutical company developing pacibekitug, an anti-IL-6 mAb, as a treatment option for atherosclerotic cardiovascular disease Pacibekitug is a promising targeted therapy with [...]
Tourmaline Bio Enters into Agreement to be Acquired by Novartis AG
09/09/2025
– Novartis to acquire Tourmaline Bio for $48.00 per share in cash for a total equity value of approximately $1.4 billion – – Transaction reflects the potential of Tourmaline’s pacibekitug, a long-acting, fully-human, [...]
Valley Wellness to open luxury behavioral health facility in Corona, CA
09/09/2025
CORONA, Calif., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Valley Wellness , a California-based behavioral health treatment company, has announced the opening of its first facility in Corona, CA. The company has selected a 4.2- [...]
Go North Hemp Forecasts 100% Year-Over-Year Revenue Growth in 2025, Strengthening Market Leadership in Next-Gen Hemp Ingredients
08/09/2025
TIGARD, Ore., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Go North Hemp, a U.S. wholesale supplier of hemp-derived ingredients, today announced it is on track to double annual revenue in 2025 versus 2024, supported by expanding [...]
Shiny Smile Veneers Surpasses 100,000 Smiles Transformed in 2025 as Demand for Lifestyle Dental Health Solutions Grows
08/09/2025
Shiny Smile Veneers, founded by practicing dentist Dr. Dean, has officially surpassed 100,000 customers in 2025. The milestone highlights the rising demand for affordable, custom-made removable veneers that combine [...]
Most Popular Legal Steroids for Muscle Building from CrazyBulk: Best Selling Steroid Alternatives for Muscle Growth and Cutting in 2025
08/09/2025
New York City, NY, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Introduction: What are the best legal steroid alternatives for muscle growth and fat loss from Crazybulk’s supplement range. In 2025, demand for legal steroid [...]
Persephone Biosciences Hits 10,000 Families on Waitlist for First-of-Its-Kind Infant Synbiotic
08/09/2025
In just over a month, 10,000 parents and caregivers joined the waitlist for Persephone’s science-driven synbiotic designed to restore critical gut microbes in babies. The milestone underscores the urgent demand for [...]
Tren Cycle for Bodybuilding: CrazyBulk Introduce Test and Tren Stack for Muscle Growth, Dosage, Benefits & Results
08/09/2025
New York City, NY, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Introduction: The Ultimate Tren Cycle and Why the Tren and Test Conversation Dominates Modern Bodybuilding Tren and Test dominate the narrative of contemporary [...]
Beyond Air Announces Exercise of Warrants for $3.25 Million of Gross Proceeds
08/09/2025
GARDEN CITY, N.Y., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of [...]
Claisen Launches Direct-to-Consumer Personalized Kits for Gastrointestinal Diseases (Heartburn, Bloating, and Gas)
08/09/2025
BOSTON, MA, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Claisen Inc. , a telemedicine and digital gastrointestinal health company, today announced the launch of personalised, direct-to-consumer gut health kits that help patients [...]

Pages